Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|March 18, 2003
BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular featuresSandrine Roulland, Pierre Lebailly, Gilbert Roussel, et al.
International Journal of Cancer|July 28, 2009
Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosisEmilie Brotin, Matthieu Meryet-Figuière, Karin Simonin, et al.
Nuclear Medicine Communications|August 31, 2007
Improvement of semi-quantitative small-animal PET data with recovery coefficients: a phantom and rat studyNicolas Aide, Marie-Hélène Louis, Soizic Dutoit, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 29, 2015
Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulationMarie-Laure Bonnefond, Bernard Lambert, Florence Giffard, et al.
The Journal of Experimental Medicine|June 10, 2009
Agricultural pesticide exposure and the molecular connection to lymphomagenesisJulie Agopian, Jean-Marc Navarro, Anne-Claire Gac, et al.
Leukemia Research|December 1, 2009
ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemiaSylvain P Chantepie, Dominique Vaur, Christoph Grunau, et al.
Cancer Letters|March 22, 2014
PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is inducedAbdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier, et al.
Oncotarget|October 20, 2018
Inhibition of store-operated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to anti-BclxL strategies through Mcl-1 down-regulationMarie-Laure Bonnefond, Romane Florent, Sophie Lenoir, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory diseaseNicolas Aide, Laurent Poulain, Mélanie Briand, et al.
Clinical Chemistry|February 11, 2020
Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian CarcinomaNicolas Vigneron, Mégane Vernon, Matthieu Meryet-Figuière, et al.
Pageof 5